Avinya Ventures

Avinya Ventures is a Bengaluru-based pre-seed and seed fund writing cheques in the $250k-$1M range to early-stage Indian founders building digital health, health IT software, and broader AI-enabled platforms. The firm’s positioning is generalist tech with a tilt toward scalable software businesses rather than asset-heavy clinical operations. For founders, Avinya is best understood as a small-cheque early lead or co-investor that helps anchor the first institutional round and unlocks downstream Indian VC syndicates in Bengaluru and Mumbai. The right founder profile is a domain-credible operator building B2B health software, RCM, EHR, or workflow automation tools with early customer signal, who needs $500k-$1M to reach Series A milestones. Pre-revenue founders without clear ICP definition, deep biotech plays, and US-anchored teams without India presence should look elsewhere. The cleanest entry path is via the Bengaluru founder community, an existing Avinya portfolio CEO, or warm introductions from larger Indian VC partners who often refer earlier-stage opportunities downstream. In the first meeting, lead with concrete pipeline conversion data, healthcare-specific compliance posture (NDHM, ABDM, DPDP), and a credible Series A narrative that names likely follow-on investors. Caveats: the fund is relatively young, its public deal footprint is modest, and follow-on reserves at the seed end of the Indian market are typically thin, so founders should be realistic about Avinya’s ability to bridge into Series A on its own. The firm does not market itself as AI-thesis-driven, so AI-heavy founders should bring independent technical credibility rather than rely on Avinya for diligence depth. Request a recent deal sheet and reserves policy explicitly during initial diligence.